Please try another search
Yifan Pharmaceutical Co., Ltd. engages in the researches and develops, produces, and sells macromolecules, biosimilars, generic drugs, small molecules, synthetic biologics, and special traditional Chinese medicines in China Southeast Asia, Europe, North America, Singapore, South Korea, Italy, Germany, and the United States, and internationally. It offers oral slow controlled release preparations, micron suspensions, micelles for injection, and liquid preparations. The company also focuses on hematologic maliganancies, inflammatory, endocrinology/metabolic, dermatological, gynecologic, and pediatric diseases, etc. The company was formerly known as Yifan Xinfu Pharmaceutical Co., Ltd. and changed its name to Yifan Pharmaceutical Co., Ltd. in October 2016. Yifan Pharmaceutical Co., Ltd. was founded in 2000 and is headquartered in Hangzhou, China.
Name | Age | Since | Title |
---|---|---|---|
Yi Qun Ye | 50 | 2014 | Director |
Ben Yu Zhou | 50 | 2014 | Director |
Xian Feng Cheng | 55 | 2014 | Chairman of the Board of Directors & GM |
Xing Lin | 37 | 2012 | Deputy GM & Director |
Deqi Feng | 44 | 2016 | Board Secretary, Deputy GM & Director |
Hong Cheng Gen | 60 | 2019 | Independent Director |
Xintu Lei | 51 | 2019 | Independent Director |
Lian Chun Zhang | 50 | 2014 | Member of the Supervisory Board |
Jun Wang | 52 | 2018 | Supervisor |
Hongquan Liu | 65 | 2020 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review